Development and characterization of 1C6-203, a new monoclonal antibody specific to human thymidine phosphorylase.
about
Metronomic doxifluridine chemotherapy combined with the anti-angiogenic agent TNP-470 inhibits the growth of human uterine carcinosarcoma xenografts.Predictive and prognostic markers for invasive breast cancer.Influence of angiogenetic factors and matrix metalloproteinases upon tumour progression in non-small-cell lung cancerThe expression of thymidine phosphorylase in cancer-infiltrating inflammatory cells in stomach cancerHigh expression of thymidine phosphorylase in basal-like breast cancers: Stromal expression in EGFR- and/or CK5/6-positive breast cancers.Prognostic value of thymidine phosphorylase expression in breast carcinoma.
P2860
Development and characterization of 1C6-203, a new monoclonal antibody specific to human thymidine phosphorylase.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Development and characterizati ...... human thymidine phosphorylase.
@ast
Development and characterizati ...... human thymidine phosphorylase.
@en
type
label
Development and characterizati ...... human thymidine phosphorylase.
@ast
Development and characterizati ...... human thymidine phosphorylase.
@en
prefLabel
Development and characterizati ...... human thymidine phosphorylase.
@ast
Development and characterizati ...... human thymidine phosphorylase.
@en
P2093
P2860
P1476
Development and characterizati ...... human thymidine phosphorylase.
@en
P2093
P2860
P304
P356
10.1177/002215540104900113
P577
2001-01-01T00:00:00Z